Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0B5YS
|
|||
| Former ID |
DNC006146
|
|||
| Drug Name |
T83193
|
|||
| Synonyms |
vanillin; 4-Hydroxy-3-methoxybenzaldehyde; 121-33-5; Vanillaldehyde; Vanillic aldehyde; Vanilla; p-Vanillin; 2-Methoxy-4-formylphenol; Vanilline; Lioxin; 4-Hydroxy-m-anisaldehyde; 3-Methoxy-4-hydroxybenzaldehyde; Zimco; Benzaldehyde, 4-hydroxy-3-methoxy-; 4-Hydroxy-3-methoxy-benzaldehyde; Vanilin; p-Hydroxy-m-methoxybenzaldehyde; 4-Formyl-2-methoxyphenol; Methylprotocatechuic aldehyde; Vanillin (natural); 4-Hydroxy-5-methoxybenzaldehyde; m-Anisaldehyde, 4-hydroxy-; Protocatechualdehyde, methyl-; Vanillin [USAN]; Vanillin (NF)
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C8H8O3
|
|||
| Canonical SMILES |
COC1=C(C=CC(=C1)C=O)O
|
|||
| InChI |
1S/C8H8O3/c1-11-8-4-6(5-9)2-3-7(8)10/h2-5,10H,1H3
|
|||
| InChIKey |
MWOOGOJBHIARFG-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 121-33-5
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
3281, 4017, 79257, 100930, 474022, 587823, 607367, 2467553, 3134857, 4339309, 7847159, 8143801, 8151015, 10505673, 11405480, 11528283, 11528509, 14709529, 15219260, 16956663, 17389583, 24430806, 24715056, 24890051, 24890052, 24900708, 24900731, 24901469, 24901470, 26512239, 26753082, 29204664, 36527317, 48415161, 48417374, 48420488, 48421924, 48424279, 48425731, 49743000, 50105631, 51060675, 53787935, 57320801, 57654724, 57841336, 85090369, 87570691, 87577869, 87643260
|
|||
| ChEBI ID |
CHEBI:18346
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6412). | |||
| REF 2 | Inhibition of GABA shunt enzymes' activity by 4-hydroxybenzaldehyde derivatives. Bioorg Med Chem Lett. 2006 Feb;16(3):592-5. | |||
| REF 3 | Novel monoamine oxidase inhibitors: a patent review (2012 - 2014).Expert Opin Ther Pat. 2015 Jan;25(1):91-110. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.